Purchase Order 75N91020P00528

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $12,130.80 on June 11, 2020, with ultimate completion on June 14, 2021. The order covers a maintenance agreement on a firm fixed price basis. Work is performed in San Diego, California. No set-aside was used.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $20,198.50 in scientific equipment, effective February 9, 2021, with completion targeted March 31, 2021. Performance occurs in San Diego, California. The order is firm fixed-price with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc., valued at $24,738.00, on July 25, 2017, for software and hardware services, with an ultimate completion date of July 24, 2018. Work is performed in San Diego, California. The order is priced on a firm fixed price basis with no set-aside used.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $16,085.00 on May 17, 2019, with ultimate completion on June 14, 2020. Performance occurs in Bethesda, Maryland. The order is a firm fixed price service agreement with no set-aside applied.</p>

<p>The National Cancer Institute issued a $13,043.75 delivery order to Illumina, Inc. on May 2, 2018, with a completion date of May 22, 2018, at firm fixed price.</p> <p>Place of performance is San Diego, CA 92122. The order was issued without set-aside designation. No parent vehicle is identified in the source.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $4,066.13 on December 4, 2017, with a completion date of January 31, 2018. The order covers a maintenance agreement for Illumina sequencing equipment. Work is performed in San Diego, California. The purchase order carries firm fixed price terms and no set-aside designation.</p>

<p>The National Cancer Institute issued a $105,047.93 delivery order to Illumina, Inc. on May 3, 2021, for biological kits with an ultimate completion date of June 2, 2021.</p> <p>Place of performance is San Diego, CA 92122. The order is priced on a firm fixed price basis with no set-aside applied.</p>

<p>The National Cancer Institute issued a $166,466.54 delivery order to Illumina, Inc. on June 17, 2020, for reagents and consumables, with an ultimate completion date of July 17, 2020.</p> <p>Place of performance is San Diego, CA 92122. The order is priced on a firm fixed-price basis with no set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $26,357.76 on June 29, 2017, with an ultimate completion date of June 30, 2018. Work is performed in San Diego, California. The order covers sequencing reagents, consumables, or related biotechnology products and services. No set-aside category applied to this procurement.</p>

<p>The National Cancer Institute issued a delivery order to Illumina, Inc. on March 4, 2021, with a ceiling value of $30,294.00 for Illumina reagents and consumables. Place of performance is San Diego, CA 92122. The order was firm fixed price with an ultimate completion date of July 5, 2021.</p>